Zobrazeno 1 - 10
of 822
pro vyhledávání: '"noacs"'
Autor:
Rithvik Ramesh, Lakshmi Narasimhan Ranganathan, Sriram Raguraman, Kamlesh Jayakumar, Braveen Rajamanoharan, Varun Kishore Loganathan, Philo Hazeena, Sundar Shanmugam, Deepa Avadhani, Karthik Sankar
Publikováno v:
Annals of Indian Academy of Neurology, Vol 27, Iss 4, Pp 393-397 (2024)
Introduction: Cerebral Venous Thrombosis (CVT) poses a rare but life-threatening challenge, warranting meticulous treatment approaches. Traditional therapy involves Vitamin K Antagonists (VKAs), but Newer Oral Anticoagulants (NOACs) offer potential a
Externí odkaz:
https://doaj.org/article/4b2f980dd8944ef8b39cde08162efdc4
Publikováno v:
Asian Journal of Surgery, Vol 47, Iss 10, Pp 4260-4270 (2024)
The differences in the safety and efficacy of anticoagulation between different types of new oral anticoagulants(NOACs) and low molecular weight heparin(LMWH) are still controversial. The main purposes of this study were to analyze safety and efficac
Externí odkaz:
https://doaj.org/article/209814a57d55492baebfa2225935cdbf
Towards an emerging role for anticoagulants in cancer therapy: a systematic review and meta-analysis
Autor:
Huda Moutaz Asmael Al-Azzawi, Syed Ameer Hamza, Rita Paolini, Fizza Arshad, Romeo Patini, Lorraine O’Reilly, Michael McCullough, Antonio Celentano
Publikováno v:
Frontiers in Oral Health, Vol 5 (2024)
BackgroundAnticoagulants, renowned for their role in preventing blood clot formation, have captivated researchers’ attention for the exploitation of their potential to inhibit cancer in pre-clinical models.ObjectivesTo undertake a systematic review
Externí odkaz:
https://doaj.org/article/787c151e9f334dac82f82326ba75534e
Autor:
Paisit Kosum, Noppachai Siranart, Kunathip Nissaipan, Wattakorn Laohapiboolrattana, Walit Sowalertrat, Kanittha Triamamornwooth, Rawiwan Arunphan, Apiradee Sriyom, Voravut Rungpradubvong
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Warfarin remains the most prescribed oral anticoagulant of choice in atrial fibrillation (AF) patient in resource-limited settings. Despite evidence linking Time in Therapeutic Range (TTR) to patient outcomes, its use in clinical practice is
Externí odkaz:
https://doaj.org/article/3fa8885d8cc14adfb51741c69c0dfa2b
Autor:
Reddy VY, Zhong Y, McGovern AM, Amorosi SL, Gavaghan MB, Hertz DS, Low K, Freeman S, Holmes DR Jr
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 16, Pp 81-96 (2024)
Vivek Y Reddy,1 Yue Zhong,2 Alysha M McGovern,2 Stacey L Amorosi,2 Meghan B Gavaghan,3 Deanna S Hertz,3 Kaywei Low,3 Scott Freeman,3 David R Holmes Jr4 1Icahn School of Medicine at Mount Sinai, New York, NY, USA; 2Health Economics and Market Access,
Externí odkaz:
https://doaj.org/article/0d749dd15edd41598379b591804f52e5
Publikováno v:
Biomolecules, Vol 14, Iss 8, p 956 (2024)
The use of non-vitamin K antagonist oral anticoagulants (NOACs) has brought a significant progress in the management of cardiovascular diseases, considered clinically superior to vitamin K antagonists (VKAs) particularly in the prevention and treatme
Externí odkaz:
https://doaj.org/article/e0659b517a4b4f26850d2959d64a2482
Autor:
Abdirahman Ahmed S, Hassan MO, Abdi IA, Mohamud MA, Waberi MM, Elmi Abdi A, Hassan Fujeyra AM, Ali AA, Sheikh Hassan M
Publikováno v:
International Medical Case Reports Journal, Vol Volume 16, Pp 623-626 (2023)
Said Abdirahman Ahmed,1 Mohamed Omar Hassan,1 Ishak Ahmed Abdi,1 Mohamed Abdullahi Mohamud,1 Mohamud Mire Waberi,1 Ahmed Elmi Abdi,1 Abdullahi Mohamed Hassan Fujeyra,2 Abdijalil Abdullahi Ali,3 Mohamed Sheikh Hassan4 1Department of Cardiology at Moga
Externí odkaz:
https://doaj.org/article/67e943f4d368467a98874f91866861c5
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: Novel oral anticoagulants (NOACs) have been recommended by guidelines as the first-line drugs for preventing cardiogenic stroke. We aimed to provide an overview of the prescription trends and dosing appropriateness of NOACs in China.Metho
Externí odkaz:
https://doaj.org/article/29751f9e2c804a9e8e62e49288d50139
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundsNon-vitamin K antagonist oral anticoagulants (NOACs) have been recommended as the first choice over warfarin for non-valvular atrial fibrillation (AF). However, there is limited data about their usage in mainland China.MethodsPrescriptions
Externí odkaz:
https://doaj.org/article/7236ba470b2f48ae95581e8e2696404d
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-5 (2023)
Abstract Background Coronavirus disease 2019 was spread worldwide, as a pandemic, from December 2019. Venous thromboembolism events can inflict patients with coronavirus disease 2019 during the hospitalization or convalescent period. Therefore, monit
Externí odkaz:
https://doaj.org/article/f4200fa124844a06b255555321fd90e5